Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Sales | 9,954 | 8,560 | 11,021 | 0 |
Cost of Goods | 3,920 | 3,290 | 4,325 | N/A |
Gross Profit | 6,034 | 5,270 | 6,696 | N/A |
Operating Expenses | 10,621 | 9,392 | 8,384 | 0 |
Operating Income | -3,667 | -3,832 | -1,363 | N/A |
Interest Expense | 683 | 658 | 637 | 0 |
Other Income | 57 | -56 | -105 | 0 |
Pre-tax Income | -4,293 | -4,546 | -2,105 | 0 |
Income Tax | -9 | 39 | 38 | N/A |
Net Income Continuous | -4,284 | -4,585 | -2,143 | N/A |
Net Income | $-4,284 | $-4,585 | $-2,143 | $N/A |
EPS Basic Total Ops | -2.44 | -2.65 | -1.59 | N/A |
EPS Basic Continuous Ops | -1.81 | -2.00 | -0.94 | N/A |
EPS Diluted Total Ops | -2.44 | -2.65 | -1.59 | N/A |
EPS Diluted Continuous Ops | -1.81 | -2.00 | -0.94 | N/A |
EBITDA(a) | $-2,696 | $-2,910 | $-464 | $N/A |